With an average analyst rating of buy, Amgen is clearly an analyst favorite. But the analysts could be wrong. Is AMGN overvalued at today's price of $304.45? Let's take a closer look at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback